In contrast, studies on patient biopsies exhibited that RhoB expression levels are dramatically decreased in several tumor types including head and neck, lung and ovary carcinoma, when tumors become more aggressive and invasive[10, 9, 26]. This evidence concerns the gene RHOB and neoplasm.